MuniMetrics MVP v6.6.5

Recommendation: **Watch** ## Core Thesis: State of Illinois General Obligation Bonds screen as **Buy-leaning but not yet final-approval ready** based on the rule-based credit score of **83** and a reported fiscal 2024 surplus of **$3.138 billion** on **$74.749 billion** of total revenue and **$71.611 billion** of total expenses. Reported unrestricted reserves/fund balance were **$4.224 billion**, and the annual trend row shows **$0 temporary funding**, producing a **0.0% temporary-funding-to-revenue ratio** and no adjustment between reported and adjusted surplus. However, the review remains at **Draft / Preliminary** stage, only **one year** of financial trend data is provided, debt service is shown as **$0** in the supplied row, and several document-mining findings remain unresolved, including a system red flag that a **high-risk temporary funding reference requires analyst review**. Until those items are validated, the appropriate internal stance is **Watch** rather than final Buy. ## Why This Bond May Be Attractive: - **General obligation bond type** provides a broad state credit framework for review. - Fiscal 2024 reported results show a **$3.138 billion surplus**, with adjusted surplus also **$3.138 billion**. - Temporary funding dependency is currently measured as **Low**, with **$0 temporary funding** in the annual financial trend row. - Temporary funding equals **0.0% of revenue**, indicating no quantified reliance on temporary sources in the provided financial data. - Reported unrestricted reserves/fund balance totaled **$4.224 billion** in fiscal 2024. - Rule-based score is relatively strong at **83**, with high component scores for: - **Financial Trend Strength: 25** - **Temporary Funding Dependency: 20** - **Debt Burden / Coverage: 15** - **Economic Resilience: 14** ## Why This Bond Requires Caution: - The rule-based recommendation is **Watch**, not final Buy, because analyst validation is required. - The system specifically flags: **“High-risk temporary funding reference requires analyst review.”** - Only **one fiscal year** of annual financial trend data is provided, limiting trend analysis. - Debt service is listed as **$0** in the fiscal 2024 trend row, so debt-service coverage cannot be evaluated from the supplied data. - Several temporary/artificial funding findings are unapproved and require analyst review. - Governance / disclosure quality score is relatively low at **4**, and bond structure protections score is **5**. - The review is still **Preliminary**, in **Draft** workflow stage, with analyst recommendation marked **To Be Determined**. ## Temporary Funding / Artificial Support Analysis: Based on the annual financial trend data, temporary funding does **not currently appear to distort reported financial strength**, because fiscal 2024 temporary funding is listed as **$0**, and the reported surplus and adjusted surplus are both **$3.138 billion**. However, the document-mining results include unresolved findings that need analyst validation: - **Temporary Funding / Operating Support Indicators** - **CARES**: The ACFR excerpt states that operating grants and contributions decreased mostly due to a decrease in Federal CARES Act funds as remaining funds were spent down. This supports the need to determine whether prior operating support has rolled off and whether current-year operations remain structurally balanced without it. - **ESSER**: Classified as Temporary Funding with medium risk and high confidence, but the extracted finding text does not clearly quantify an operating revenue impact in the supplied data. - **Capital-Only / Restricted or Non-Recurring Items** - **Provider Relief Fund / Healthcare Provider Relief Fund**: Classified as **Capital-Only Funding** with **High** risk and medium confidence. The excerpt references funds included in budgetary-basis reporting, but no quantified impact on operating results is provided. - **Reimbursement Funding** - **Reimbursement**: The finding relates to internal service funds accounting for services provided to state agencies on a reimbursement basis. This may not represent artificial operating support, but it is classified as **High** risk and requires analyst review. - **Unclear Items Requiring Analyst Review** - **Budget stabilization**: The Budget Stabilization Account is included within the General Fund structure, but the supplied excerpt does not quantify any draw or use. - **State aid**: The Common School Account provides funding for elementary and secondary education agencies, including General State Aid, but no temporary-funding impact is quantified. - **Federal grant**: The Water Revolving Fund increase was attributed mainly to increased federal grant revenue; the operating versus capital nature should be confirmed. - **COVID**: Fiscal 2023 included a **$450 million** appropriation as a loan from the General Revenue Account to the Unemployment Compensation Trust Fund to aid repayment of federal advances related to the COVID-19 pandemic. This is not quantified in fiscal 2024 operating results in the supplied data. ## Reported vs. Adjusted Credit View: There is **no numerical difference** between the reported and adjusted credit view in the supplied data: - Reported fiscal 2024 surplus: **$3.138 billion** - Adjusted fiscal 2024 surplus: **$3.138 billion** - Temporary funding: **$0** - Temporary funding as a percentage of revenue: **0.0%** The rule-based model therefore does not currently reduce fiscal 2024 results for temporary or artificial support. The main credit distinction is qualitative: the reported financial position appears solid based on the supplied fiscal 2024 row, but unresolved document-mining flags prevent final approval until the analyst confirms that temporary, capital-only, reimbursement, and unclear items do not materially inflate recurring operating performance. ## Key Follow-Up Before Final Approval: - Confirm whether the **$0 temporary funding** entry in the fiscal 2024 annual trend row is complete and analyst-approved. - Validate each unapproved temporary/artificial funding finding, especially: - CARES spend-down impact - ESSER classification and relevance - Provider Relief / Healthcare Provider Relief Fund treatment - Reimbursement funding classification - Budget Stabilization Account usage - Federal grant treatment in the Water Revolving Fund - COVID-related Unemployment Compensation Trust Fund loan context - Determine whether any of the flagged items affected recurring operating revenue or only capital, restricted, reimbursement, or non-operating funds. - Obtain or populate debt service data, since fiscal 2024 debt service is currently shown as **$0**. - Add additional fiscal years if available to assess trend durability beyond the single 2024 data point. - Complete senior analyst review given the review status is **Preliminary / Draft** and mentor status is **Not Submitted**. ## Final Analyst Note: The credit screens positively on fiscal 2024 reported and adjusted results, with a **$3.138 billion surplus**, **$4.224 billion** of reserves/fund balance, and **0.0% quantified temporary funding dependency**. However, unresolved document-mining flags and missing debt-service context keep the thesis at **Watch** pending analyst validation.